Page 7 - Sanket Koul

Credai's Budget wish list: Revise affordable housing price cap to ₹90 lakh

This comes even as affordable homes have been seeing a drop in demand as well as supply in Tier-I markets such as Delhi NCR and Mumbai

JP Nadda meets Afghan health minister, reiterates medical support

Medical visas, supply of drugs and CT scan machines figure in discussions between both countries

Max to invest over ₹1K cr in 450-bed Pune hospital, eyes West India growth

This will be Max Healthcare's fourth facility in Maharashtra after the 350-bed Nanavati Max Hospital situated in Mumbai and 212-bed Alexis Hospital in Nagpur

Elan Group to invest ₹1,600 cr for ultra luxury housing in Gurugram

The first phase will offer 230 four-bedroom residences across five towers, with unit sizes ranging from around 4,300 to 4,500 square feet

India can be global hub for research, learning with state-led reforms: CEA

India is uniquely placed to benefit from demographics, technology and AI adoption, but state-led reforms under NEP 2020 will determine whether the country can emerge as a global research destination

NMC asks colleges to set up panels to track prescription practices

NMC has asked medical colleges to set up sub-committees to monitor prescription practices and stress clear, legible handwriting as part of medical training.

New higher education regulator won't have funding powers: Pradhan

Lack of clarity on funding of higher education institutes was raised by several experts

Bill to set up single higher education commission tabled, sent to JPC

The introduction of the bill faced sharp resistance from the opposition

IHH plans India expansion after Fortis open offer, to add 2K beds by 2028

Analysts say IHH's play may include improving revenue per bed by lifting clinical mix

Golden Growth Fund deploys ₹58 cr in South Delhi luxury floor projects

Golden Growth Fund said it has deployed Rs 58 crore to acquire two South Delhi projects in Anand Niketan and Niti Bagh for luxury floors, with an estimated sales potential of Rs 85 crore

GLP-1 weight-loss drugs likely to see value growth slowing down

Entry of generics post March 2026, patient dropouts to affect sales values, say experts

With an eye on rivals, Novo Nordisk launches diabetes drug Ozempic in India

With Mounjaro gaining ground, launch comes just three months before Novo loses patent for semaglutide

Novo Nordisk challenges HC order permitting Dr Reddy's semaglutide exports

Novo Nordisk's appeal is listed for hearing on Friday before a bench of Justice C Hari Shankar and Justice Om Prakash Shukla

UK sees rise in Indian students, boosts research ties: UCL President

University College London sees a 19-26% surge in Indian student enrolments for academic year 2025-26, focusing on partnerships and scholarships instead of a foreign campus

MPs' forum seeks action on lack of funds for treating rare diseases

A bipartisan parliamentary forum has warned that funding shortages and administrative delays under India's rare disease policy are disrupting life-saving treatment

Delhi HC allows Sun Pharma to export semaglutide, restricts sale in India

The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based drugs to countries where Novo Nordisk holds no patent, but barred sales in India until March 2026

Novo Nordisk moves HC to stop Sun Pharma's weight-loss drug launch

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for Type 2 diabetes and weight management

One-fifth of 365 shopping centres have become ghost malls: Knight Frank

Ghost malls hold over Rs 350 crore in annual rental potential: Knight Frank report

Price cuts drove market gains in November for Novo Nordisk's Wegovy

Novo Nordisk cut Wegovy prices in mid-November, driving a 70% consumption jump and higher market share. Pharmarack data show Lilly's Mounjaro still dominates sales

Drop in AQI levels across India lead to rise in respiratory drugs sales

Winter triggered ailments no longer just a seasonal fluctuation but an escalating public health trigger due to air pollution, say experts